Furthermore, the in vivo results showed that silencing ANGPT2 significantly reduced the fluorescence intensity in MYBL1-overexpression tumor cells (Fig. 5E) and downregulation of ANGPT2 dramatically reduced the number of CD31-positive microvessels in MYBL1 transfected mice (Fig. 5F). This evidence concerns the gene MYBL1 and neoplasm.